Log in to save to my catalogue

The RAD51D E233G variant and breast cancer risk: population-based and clinic-based family studies of...

The RAD51D E233G variant and breast cancer risk: population-based and clinic-based family studies of...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_69605969

The RAD51D E233G variant and breast cancer risk: population-based and clinic-based family studies of Australian women

About this item

Full title

The RAD51D E233G variant and breast cancer risk: population-based and clinic-based family studies of Australian women

Publisher

Boston: Springer US

Journal title

Breast cancer research and treatment, 2008-11, Vol.112 (1), p.35-39

Language

English

Formats

Publication information

Publisher

Boston: Springer US

More information

Scope and Contents

Contents

RAD51D
is a homolog of the RAD51 protein, which is known to be an important component of the DNA repair pathway. A rare missense variant in the
RAD51D
gene, E233G (c.A > G), has been reported to be more prevalent in breast cancer cases from specific multiple-case breast cancer families, with an odds ratio of 2.6 (95% confidence interval (C...

Alternative Titles

Full title

The RAD51D E233G variant and breast cancer risk: population-based and clinic-based family studies of Australian women

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_69605969

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_69605969

Other Identifiers

ISSN

0167-6806

E-ISSN

1573-7217

DOI

10.1007/s10549-007-9832-0

How to access this item